日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

ADT-030, a novel PDE10 inhibitor, demonstrates potent antitumor activity in pancreatic ductal adenocarcinoma

ADT-030 是一种新型 PDE10 抑制剂,在胰腺导管腺癌中表现出强大的抗肿瘤活性。

Bandi, Dhana Sekhar Reddy; Nagaraju, Ganji Purnachandra; Sarvesh, Sujith; Foote, Jeremy B; Keeton, Adam B; Chen, Xi; Ramirez-Alcantara, Veronica; Holmes, Thomas; Akce, Mehmet; Singh, Anju; Powell, Craig M; Behera, Santosh; Azmi, Asfar S; Nurmemmedov, Elmar; Babic, Ivan; Gorman, Gregory S; Coward, Lori; Buchsbaum, Donald J; Maxuitenko, Yulia Y; Piazza, Gary A; El-Rayes, Bassel F

ADT-1004: a first-in-class, oral pan-RAS inhibitor with robust antitumor activity in preclinical models of pancreatic ductal adenocarcinoma

ADT-1004:一种首创的口服泛RAS抑制剂,在胰腺导管腺癌的临床前模型中具有强大的抗肿瘤活性

Bandi, Dhana Sekhar Reddy; Nagaraju, Ganji Purnachandra; Sarvesh, Sujith; Carstens, Julienne L; Foote, Jeremy B; Graff, Emily C; Fang, Yu-Hua D; Keeton, Adam B; Chen, Xi; Valiyaveettil, Jacob; Berry, Kristy L; Bae, Sejong; Akce, Mehmet; Gorman, Greg; Yoon, Karina J; Manne, Upender; Boyd, Michael R; Buchsbaum, Donald J; Azmi, Asfar S; Maxuitenko, Yulia Y; Piazza, Gary A; El-Rayes, Bassel F

A Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth and Induces Antitumor Immunity in Gastrointestinal Cancer.

一种具有独特作用机制的泛 RAS 抑制剂可抑制肿瘤生长并诱导胃肠道癌症的抗肿瘤免疫

Foote Jeremy B, Mattox Tyler E, Keeton Adam B, Chen Xi, Smith Forrest T, Berry Kristy, Holmes Thomas W, Wang Junwei, Huang Chung-Hui, Ward Antonio, Mitra Amit K, Ramirez-Alcantara Veronica, Hardy Cherlene, Fleten Karianne G, Flatmark Kjersti, Yoon Karina J, Sarvesh Sujith, Nagaraju Ganji P, Bandi Dhana Sekhar Reddy, Maxuitenko Yulia Y, Valiyaveettil Jacob, Carstens Julienne L, Buchsbaum Donald J, Yang Jennifer, Zhou Gang, Nurmemmedov Elmar, Babic Ivan, Gaponeko Vadim, Abdelkarim Hazem, Boyd Michael R, Gorman Greg, Manne Upender, Bae Sejong, El-Rayes Bassel F, Piazza Gary A

Evaluation of a Novel Pan-RAS Inhibitor in 3D Bioprinted Tumor Models

在3D生物打印肿瘤模型中评估一种新型泛RAS抑制剂

De Nobrega, Daniela D; Eiler, Logan C; Ahirwar, Parmanand; Nallapu, Sonika; Rawal, Urvi P; Crawford, Chelsea L; Buchsbaum, Donald J; Keeton, Adam B; Maxuitenko, Yulia Y; Chen, Xi; Piazza, Gary A; Tsung, Allan; Budhwani, Karim I

Editorial: RAS inhibitor therapy of cancer

社论:RAS抑制剂治疗癌症

Buchsbaum, Donald J; Nassar, Nicolas N; Piazza, Gary A

Potency and selectivity of a novel pan-RAS inhibitor in 3D bioprinted organoid tumor models

新型泛RAS抑制剂在3D生物打印类器官肿瘤模型中的效力和选择性

De Nobrega, Daniela; Eiler, Logan C; Ahirwar, Parmanand; Rawal, Urvi P; Crawford, Chelsea L; Buchsbaum, Donald J; Keeton, Adam B; Maxuitenko, Yulia Y; Chen, Xi; Piazza, Gary A; Tsung, Allan; Budhwani, Karim I

Editorial: Targeting the Wnt/β-catenin signaling pathway in cancer

社论:靶向Wnt/β-catenin信号通路治疗癌症

Patergnani, Simone; Buchsbaum, Donald J; Piazza, Gary A

PDE5 and PDE10 inhibition activates cGMP/PKG signaling to block Wnt/β-catenin transcription, cancer cell growth, and tumor immunity

PDE5 和 PDE10 抑制剂可激活 cGMP/PKG 信号通路,从而阻断 Wnt/β-catenin 转录、癌细胞生长和肿瘤免疫。

Piazza, Gary A; Ward, Antonio; Chen, Xi; Maxuitenko, Yulia; Coley, Alex; Aboelella, Nada S; Buchsbaum, Donald J; Boyd, Michael R; Keeton, Adam B; Zhou, Gang

B7-H3-targeted Radioimmunotherapy of Human Cancer

B7-H3靶向放射免疫疗法治疗人类癌症

Kasten, Benjamin B; Ferrone, Soldano; Zinn, Kurt R; Buchsbaum, Donald J

Histone deacetylase inhibition promotes intratumoral CD8(+) T-cell responses, sensitizing murine breast tumors to anti-PD1.

组蛋白去乙酰化酶抑制可促进肿瘤内 CD8(+) T 细胞反应,使小鼠乳腺肿瘤对 PD-1 抗体敏感

McCaw Tyler R, Li Mei, Starenki Dmytro, Liu Mingyong, Cooper Sara J, Arend Rebecca C, Forero Andres, Buchsbaum Donald J, Randall Troy D